Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-09-24
1986-11-11
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3743, C07K 710
Patent
active
046223126
ABSTRACT:
Novel growth hormone releasing factor analogs in which glycine at position 15 is replaced by appropriately selected amino acids demonstrate enhanced potency for the release of growth hormone and the analogs can be administered to a subject having a deficiency of growth hormone.
REFERENCES:
patent: 3698912 (1972-10-01), Winitz
patent: 4529595 (1985-07-01), Rivier et al.
patent: 4562175 (1985-12-01), Chang et al.
Yue et al., Diabetes, 24, 625-632 (1975).
Guillemin et al., Science, 218, 585-587 (1982).
Lance et al., Biochemical and Biophysical Research Communications, 119, No. 1, 265-272 (1984).
Ling, et al., Biochemical and Biophysical Research Communications, 123:854-861, 1984.
Rivier, et al., Letters to Nature, 300:276-278; 1982.
Guillemin, et al. Science, 218:585-587; 1982.
Felix Arthur M.
Heimer Edgar P.
Mowles Thomas F.
Coburn Patricia P.
Gould George M.
Hoffmann-La Roche Inc.
Phillips Delbert R.
Saxe Jon S.
LandOfFree
Growth hormone releasing factor analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth hormone releasing factor analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth hormone releasing factor analogs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-377269